Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19
Background COVID-19 is a respiratory disease that results in a prothrombotic state manifesting as thrombotic, microthrombotic and thromboembolic events. As a result, several antithrombotic modalities have been implicated in the treatment of this disease. This study aimed to identify if therapeutic a...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , |
| التنسيق: | article |
| منشور في: |
2021
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/13388 http://dx.doi.org/10.1136/openhrt-2021-001785 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://openheart.bmj.com/content/8/2/e001785.abstract |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|